Diabetes mellitus: channeling care through cellular discovery.
Diabetes mellitus: channeling care through cellular discovery.
复制标题
糖尿病:通过细胞发现引导护理。
DOI:
10.2174/156720210790820217
复制
发表时间:
2010-02
影响因子:
2.1
通讯作者:
Hou J
中科院分区:
文献类型:
--
作者:
Maiese K;Shang YC;Chong ZZ;Hou J
Diabetes mellitus (DM) impacts a significant portion of the world’s population and care for this disorder places an economic burden on the gross domestic product for any particular country. Furthermore, both Type 1 and Type 2 DM are becoming increasingly prevalent and there is increased incidence of impaired glucose tolerance in the young. The complications of DM are protean and can involve multiple systems throughout the body that are susceptible to the detrimental effects of oxidative stress and apoptotic cell injury. For these reasons, innovative strategies are necessary for the implementation of new treatments for DM that are generated through the further understanding of cellular pathways that govern the pathological consequences of DM. In particular, both the precursor for the coenzyme β-nicotinamide adenine dinucleotide (NAD+), nicotinamide, and the growth factor erythropoietin offer novel platforms for drug discovery that involve cellular metabolic homeostasis and inflammatory cell control. Interestingly, these agents and their tightly associated pathways that consist of cell cycle regulation, protein kinase B, forkhead transcription factors, and Wnt signaling also function in a broader sense as biomarkers for disease onset and progression.
登录
查看更多内容
影响因子:
7.4
作者:
Bethea CL;Reddy AP;Tokuyama Y;Henderson JA;Lima FB
通讯作者:
Lima FB
影响因子:
5.3
作者:
Bakker, Walbert J.;van Dijk, Thamar B.;von Lindern, Marieke
通讯作者:
von Lindern, Marieke
影响因子:
4
作者:
Bakshi, Pancham;Margenthaler, Elaina;Mullan, Michael
通讯作者:
Mullan, Michael
影响因子:
4.8
作者:
Balan, Vitaly;Miller, Gregory S.;Tzivion, Guri
通讯作者:
Tzivion, Guri
DOI:
10.1093/gerona/60.4.471
发表时间:
2005-04-01
影响因子:
5.1
作者:
Beeri, MS;Silverman, JM;Haroutunian, V
通讯作者:
Haroutunian, V